Alex-Paige Bishop

Struggling to land top scientific talent? 🧬🔬 You're not alone. As a hiring manager, it's crucial to not just fill positions but to attract and retain the best minds in the industry. Let's collaborate to revolutionise your recruitment strategy! In my experience, the key is a blend of innovative outreach and fostering a culture that top candidates seek. It's about understanding what drives them: cutting-edge projects, professional growth, and a community that values their contributions. If you're ready to elevate your hiring process, let's connect and discuss how we can partner to build your dream team. Together, we can set a new standard in scientific recruitment. #HiringStrategy #TalentAcquisition #ScientificRecruitment

4

Artificial Intelligence (AI) has become a popular topic over the last 12 months 🤖💽 Although there are a lot of unanswered questions around AI becoming more commonplace in our day to day lives, it is slowly revolutionising antibiotic discovery and transforming the way we can fight the emergence of drug-resistant bacteria. 📝 Read the full blog here to learn more: https://lnkd.in/eJBDSHAY #NESFircroft #LifeScience #ArtificialIntelligence

4

1 Comment

Propelling Careers Episode 14 is live! Spotify (https://lnkd.in/et9yzMEu) and Apple Podcast (https://lnkd.in/eapnXK5q). This is a jam packed episode - we hope you enjoy listening! In this episode, we continue with resume advice (following on from Episodes 12 and 13) and at the end, Jim Gould, PhD and I provide some critique to his CV and my resume. This episode covers topics such as: - Why it’s important to update your document on a regular basis (hint… it’s not just for job searching) - Is there a preferred order for how to list information in a CV or resume? Jim’s book, making the most of the Postdoc, https://lnkd.in/ebBmuiQY also highlights a few points for this also. - What order are recruiters reading the experience section in a resume? - Content is important but it’s also important to zoom out an make sure the resume or CV is appealing to the eye - Should social media links be included in a resume or CV? - Be intentional about what story you want to share with your resume or CV and ensure it aligns with your career interests - What should people highlight if they are moving into a different field or area from what they have focused on previously? - What do you do if you have gap years? - Should people make their resume look artistic? - How do you deal with acronyms in a resume? - Do you need to meet minimum requirements in a job add? - What about the idea of being overqualified for a role? - What document is best to use for job applications? Word, PDF, other?

13

1 Comment

🚀 Groundbreaking Discovery for Type-1 Diabetes! 🌟 Imagine managing type-1 diabetes without daily insulin! A new study led by Cardiff University reveals that Ustekinumab, a psoriasis drug, could make this a reality for kids and teens. 🔍 Key Highlights: ✨ Ustekinumab targets Th17 cells, the culprits destroying insulin-producing cells. ✨ The trial showed a 49% boost in insulin production markers after 12 months! ✨ Precision medicine at its best: Ustekinumab leaves 99% of the immune system intact. This game-changing research opens the door to a future where type-1 diabetes can be managed more easily and effectively. Further trials are on the horizon, but the future looks promising! 🌟💉🔬 Learn more on the Study here ⬇ 🔗 https://lnkd.in/eME48Nz7 #DiabetesBreakthrough #HealthcareInnovation #FutureOfMedicine #Immunotherapy #Type1Diabetes #CardiffUniversity

2

Exciting Advances in Drug Discovery and Computational Sciences! I'm thrilled to share some interesting updates from the drug discovery and computational sciences space that are propelling our industry into a new era of innovation. 🧪 Breakthroughs in Drug Repurposing: One of the most exciting trends is the acceleration of drug repurposing efforts powered by advanced data analytics and AI. By leveraging existing compounds for new therapeutic uses, researchers are fast-tracking treatments for a range of diseases. 🔍Precision Medicine with AI: Artificial intelligence is ushering in a new age of personalized medicine. AI-driven approaches analyze vast datasets to identify patient-specific biomarkers and optimize treatment strategies, leading to more effective and targeted therapies. 💻 Virtual Screening and Drug Design: Computational simulations and virtual screening techniques are becoming indispensable in drug design. These tools expedite the identification and optimization of drug candidates, reducing time and costs associated with traditional methods. The intersection of data science, AI, and biology/chemistry is reshaping how we approach drug discovery. I'm excited to connect with professionals who are passionate about driving these transformative changes. Please send me a message with the link provided if you are interested in speaking! #DrugDiscovery #ComputationalScience #AIinHealthcare #PrecisionMedicine #Bioinformatics #MachineLearning #DataScience #ArtificialIntelligence #NextPhase

12

🌟This Week in Pharma and Biotech🌟 It's been an exciting week in the world of pharma and biotech! Major strides and developments have set the stage for significant future advancements. Let’s dive into the highlights. 🩺 Earlier this week, AstraZeneca announced promising Phase III trial results for their novel cancer treatment, demonstrating a 40% increase in patient survival rates. This breakthrough has the potential to revolutionize oncological treatment, offering new hope to patients and families. It’s thrilling to see such impactful progress in cancer therapy. 💉 Additionally, GlaxoSmithKline (GSK) unveiled their new partnership with BioNTech aimed at developing cutting-edge mRNA vaccines for infectious diseases beyond COVID-19. As part of this five-year collaboration, they'll combine their expertise to explore mRNA technology’s transformative potential in tackling diseases like malaria and tuberculosis. The commitment to ongoing innovation is inspiring. 🚀 Finally, the UK government has announced additional funding of £200M for biotech startups. This initiative aims to bolster innovation and accelerate breakthrough research, ensuring the UK remains at the forefront of scientific discovery. For budding entrepreneurs in the sector, this is a game-changing development. What are your thoughts on these latest updates? Let’s discuss in the comments below. 👇 #PharmaNews #BiotechBreakthroughs #InnovationInHealthcare

5

🔬 Exciting news in cancer research! May is #SkinCancerAwareness Month, and University College London Hospitals (UCLH) is leading the way with the world's first personalized melanoma vaccine in Phase 3 trials🌟 This innovative approach tailors treatment to each patient's unique cancer mutations, potentially revolutionizing melanoma therapy. Let's raise awareness and support advancements in skin cancer research this May. Follow the link to read more: https://lnkd.in/e7frwff8 #SkinCancerAwarenessMonth #Melanoma #CancerResearch #UCLH #Innovation 🌐

13

Antibiotic resistance is one of the most pressing public health challenges of our time, not just in the UK but globally. As we grapple with bacteria that are becoming increasingly resistant to our current arsenal of antibiotics, the need for innovative solutions has never been more critical. This is where bioinformatics comes into play, offering a beacon of hope in our fight against this growing threat. Bioinformatics, the application of computational techniques to analyse biological data, is revolutionising our approach to understanding and tackling antibiotic resistance. By harnessing the power of big data, bioinformatics enables us to delve deep into the genetic makeup of bacteria, identifying the specific genes and pathways that contribute to resistance. This is crucial for the development of new antibiotics that are more targeted and effective. In the UK, where the healthcare system is already under significant strain, the role of bioinformatics is particularly vital. It allows researchers to rapidly sequence the genomes of resistant bacteria strains, tracking their spread and evolution. This surveillance is key to informing public health strategies and interventions. Moreover, bioinformatics facilitates the exploration of the vast microbial world, uncovering novel compounds that could serve as the next generation of antibiotics. But the potential of bioinformatics extends beyond just drug discovery. It also plays a pivotal role in the optimisation of antibiotic use. By analysing complex datasets, bioinformatics can help predict bacterial responses to different antibiotics, guiding more precise and personalised treatment strategies. This not only improves patient outcomes but also helps to mitigate the risk of further resistance development. The UK is already a leader in genomic research, and by investing in bioinformatics infrastructure and talent, we can further cement our position at the forefront of the fight against antibiotic resistance. Collaborations between academic institutions, healthcare providers, and the tech industry are essential to drive innovation and translate bioinformatics research into real-world solutions. In conclusion, bioinformatics is not just an accessory but a cornerstone in the UK's strategy against antibiotic resistance. It empowers us to understand the enemy better, anticipate its moves, and outsmart it at the genetic level. As we continue to face this global health crisis, the integration of bioinformatics into our public health arsenal will be instrumental in safeguarding our future. #Bioinformatics #AntibioticResistance #UKHealthcare

4

👉 UK Healthcare Update 🔬 NICE endorses wider availability of breast cancer profiling tests such as Endopredict, Oncotype DX, or Prosigna to reduce unnecessary chemo treatments. 🏥 MedTech Alert: Spectral AI predicts start of UK commercial revenues in H2 2024 with DeepView's launch for burn care diagnostics. 🛌 SleepCogni secures over £340k from Innovate UK for child insomnia study with Sheffield Children's NHS trust, enhancing device personalization with AI. 🔄 Partnership News: Vivalink's wearable tech to support Rett Syndrome VIBRANT study, aiding the development of new therapies. 💼 Acquisition Alert: Samsung Medison set to acquire Sonio, a Paris startup specializing in AI ultrasound software, for $92.7M. #HealthTech #AI #MedicalDevices #DigitalHealth #Innovation

8

Science Thursday 👩‍⚕️ : The Ultimate Guide to Industry for Physicians- Part.2 Are you a physician who is currently trying to evaluate pharma industry positions but don't even know which roles might be available to you? Following on from last week, here I have put together a summary of two additional departments and roles that you might be interested in! 🟠 Regulatory Affairs: Regulatory Affairs serves as the guardian of compliance within the pharmaceutical landscape, navigating the intricate web of regulations to ensure the timely approval and ongoing adherence of products to regulatory standards. Roles Available and Career Progression: 1. Regulatory Affairs Specialist: Manages regulatory submissions and documentation, ensuring compliance with regulatory requirements. 2. Regulatory Affairs Manager: Oversees regulatory strategies and submissions, liaising with health authorities to facilitate product approvals. 3. Regulatory Affairs Director: Provides strategic leadership in regulatory affairs, manages regulatory teams, and navigates complex regulatory landscapes. 4. Senior/Executive Director of Regulatory Affairs: Provides executive oversight, shapes regulatory strategy, and ensures alignment with corporate objectives. 5. VP of Regulatory Affairs: Provides strategic direction at the executive level, oversees global regulatory activities, and represents the company in regulatory matters. 🟠 Pharmacovigilance: Pharmacovigilance safeguards patient safety by meticulously monitoring and evaluating adverse drug reactions, ensuring the ongoing assessment and management of risks associated with pharmaceutical products. Roles Available and Career Progression: 1. Drug Safety Associate: Collects and analyzes adverse event reports, ensuring compliance with pharmacovigilance regulations. 2. Pharmacovigilance Scientist: Conducts signal detection and risk assessment activities, contributing to the evaluation of drug safety profiles. 3. Pharmacovigilance Manager: Manages pharmacovigilance operations, oversees safety surveillance activities, and ensures compliance with regulatory requirements. 4. Senior/Executive Director of Pharmacovigilance: Provides strategic leadership in pharmacovigilance, shapes risk management strategies, and oversees global safety surveillance efforts. 5. VP of Pharmacovigilance: Provides executive oversight, sets the vision and strategy for pharmacovigilance initiatives, and represents the department at the highest levels of corporate governance. Has this been helpful at all? Please let me know in the comments below! #regulatoryaffairs #FDA #Pharmacovigilance #patientsafety #medicalcareers #clinicalcareers

5

🔬 Why Clinical Trials Stop: The Role of Genetics 🧬 A groundbreaking study from Open Targets and EMBL-EBI reveals that incorporating genetic evidence into drug development can significantly reduce clinical trial failures. 🚀 🔍 Key Findings: -Researchers developed a machine learning model to analyse reasons behind early clinical trial termination. -The study found that genetic evidence halves the odds of early stoppage due to negative reasons like safety or efficacy concerns. -Genetic insights can lead to more effective and safer therapies, de-risking future clinical studies. 💡 Study Highlights: -The analysis involved 28,842 clinical trials from ClinicalTrials.gov. -Trials with strong genetic evidence supporting the target-disease relationship were less likely to stop early. -Cancer trials were notably prone to stoppage due to safety or side effects, linked to genetic constraints, multiple known physical interactors, and lack of tissue specificity. 🗣️ Expert Insight: “The results underscore the critical importance of integrating genetic evidence in drug development,” said Olesya Razuvayevskaya, Postdoctoral Research Fellow at Open Targets. “This reduces trial failures, leading to more effective and safe therapies.” #ClinicalTrials #Genetics #DrugDevelopment #MachineLearning #Bioinformatics #Pharmaceuticals #Research #HealthcareInnovation #OpenTargets #EMBL #GenomicMedicine #AIInHealthcare

3

1 Comment

Science Thursday 👩‍⚕️: the Ultimate Guide to Industry for MD/DOs Are you a physician who is currently trying to evaluate pharma industry positions but don't even know which roles might be available to you? Here I have put together a summary of the different department and roles that you might be interested in! 🟠 Clinical Development: Clinical Development is the engine that drives the research and development (R&D) process of new drugs. This section is primarily responsible for designing and executing clinical trials, which are crucial in assessing the safety and efficacy of investigational medicines. Clinical Development works closely with regulatory authorities to ensure that trials adhere to regulatory standards and guidelines. Roles Available and Career Progression: 1. Principal Investigator: Leads clinical trials, oversees patient care, and ensures compliance with study protocols and regulatory requirements. 2. Medical Monitor: Provides medical oversight during clinical trials, assessing safety data and making decisions regarding patient safety. 3. Medical Director: Provides medical and scientific leadership, contributes to trial design and data interpretation, and ensures clinical trial integrity. 4. Senior/Executive Medical Director: Provides strategic direction for clinical development programs, oversees multiple trials, and liaises with key stakeholders. 5. VP of Clinical Development: Provides executive leadership, sets the vision and strategy for clinical development initiatives, and ensures alignment with corporate goals. 🟠 Medical Affairs: Medical Affairs bridges the gap between the pharmaceutical industry and healthcare professionals, ensuring the appropriate use of drugs and providing scientific and medical expertise internally and externally. This section is involved in activities such as medical education, publication planning, and scientific communications. Roles Available/Career Progression: 1. Medical Science Liaison (MSL): Serves as the primary link between the company and healthcare professionals, providing scientific and medical information on products- this is a field based position, which usually requires frequent travelling 2. MSL Manager: Leads a team of MSLs, provides guidance on scientific communication strategies, and ensures alignment with medical objectives. 3. Director of Medical Affairs: Provides strategic direction for medical affairs initiatives, oversees medical education programs, and ensures compliance with regulations. 4. Senior/Executive Director of Medical Affairs: Provides leadership and oversight for multiple therapeutic areas or regions, develops key opinion leader relationships, and contributes to corporate strategy. 5. VP of Medical Affairs: Provides executive leadership, sets the vision and strategy for medical affairs activities, and represents the department at the executive level. More to follow on Pharmacovigilance and Reg Affairs!

10

1 Comment

I have recently been speaking with lots of candidates that are either looking or planning to start looking for an entry-level position within HEOR & Market Access. The below guide gives some nice tips on how to do so 👇

6

🌟 Why Are Professionals Changing Jobs Within Pharma & Biotech in 2024? 🌟 The pharmaceutical and biotechnology sectors are pillars of innovation and progress, yet we're seeing a significant trend of professionals leaving their positions. Understanding the reasons behind this is crucial for retaining top talent and fostering a thriving workplace. Here are the top reasons driving this shift in 2024: 💊Innovative Opportunities: The allure of startups and smaller companies that offer innovative projects and more significant roles in cutting-edge research is strong. 🧪Lack of Career Growth: Talented individuals seek continuous professional development and advancement opportunities. Stagnation is a rad flag. ⌛Work-Life Balance: The demand for flexible work arrangements has never been higher. Rigid schedules and high stress levels are pushing professionals to seek better balance elsewhere. 🤝Company Culture: A positive, inclusive, and supportive culture is vital. Toxic environments are major turn-offs. 💰Compensation & Benefits: Competitive salaries and comprehensive benefits packages are fundamental. When these don't match industry standards or employee expectations, retention suffers. Retaining top talent means addressing these core issues head-on. Companies need to prioritize employee satisfaction, career development, and a healthy work environment. 📢 Let's Talk! If you're navigating these challenges or seeking new opportunities, don't hesitate to reach out for a private chat. Together, we can explore solutions and opportunities that align with your career aspirations. 🚀 #Pharma #Biotech #CareerGrowth #WorkLifeBalance #CompanyCulture #EmployeeRetention #Innovation #CareerOpportunities

9

5 Comments

As a leading Life science recruiting company, we work across a number of Therapeutic areas connecting with a number of industry leaders with an abundance of knowledge and experience. The last 12 - 18 months have been a strange time for an industry that typically is set to battle any issue faced... An industry that develops treatments for ongoing, life changing diseases should always be full of opportunity right? Despite the lull from a number of sectors within the Pharma space, Ophthalmology is one in particular that has kept it's head above water and is continuing to develop innovative and ground breaking treatments. As an industry with an estimated value of $7.97 billion in 2023 which is set to exceed $22.68 billion by 2034, these key clients that we are consistently supporting and making global placements with see the value in their product and in turn the need to hire the best of the best. Just today I personally placed a consultant with an emerging Ophthalmology company looking to get their first product in development in the coming months and hope to have 4 in development by the end of 2025. If you want to have a conversation regarding our abilities to source top talent across the Ophthalmology space across numerous functional areas or a conversation surrounding your experience in the Ophthalmology space, get in touch today for an exploratory conversation. E: Jblock@barringtonjames.com P: +44 1293 776644 Alternatively follow the link below to book a consultation with our team https://lnkd.in/di_jBkDC

16

Over the moon to have completed my LinkedIn Acceleration Programme with #thelinkedinman, I have learned so much along the way. Even better I came 1st in my group, can't wait for my prize to arrive 😎 Anyone looking to know more about how to use LinkedIn effectively get in touch with James and Allison 😁 #linkedin #knowledge #keeponlearningguys

15

14 Comments

𝘿𝙚𝙢𝙚𝙣𝙩𝙞𝙖 𝘼𝙘𝙩𝙞𝙤𝙣 𝙒𝙚𝙚𝙠 🧠 An insightful article released earlier this week for Dementia Action Week, highlighting the achievements and research activity in the area of Alzheimer’s disease, something that lies closely to me personally. As the article states, the approval of several drugs for Alzheimer’s disease has encouraged further activity within this space for new drugs and diagnostics. New procedures to calculate tau and other biomarkers are in development. Several companies are developing diagnostic blood tests, with Roche recently winning a breakthrough device designation from the FDA for its Elecsys pTau217 plasma biomarker assay. Another company developing a tau-based blood test is Sunbird Bio, whose APEX platform is a proprietary diagnostic system that detects extracellular vesicle (EV)-bound tau proteins in blood. CEO John McDonough stated that “We don’t just have an opportunity, we have an obligation to develop these tests and make them as accessible as we can in the US and around the world”. Data shows that the Alzheimer's Market will be $15.9bn in 2030 Globally. #Tau #Diagnostics #DimentiaActionWeek

13

Propelling Careers podcast episode 11 is live! Spotify (https://lnkd.in/e5pGstsv) and Apple Podcast (https://lnkd.in/eJ57Nan7). In this episode, Jim Gould, PhD and I cover a few topics that we think are important - we may dive deeper into each of these topics in future episodes. The topics are: - how to follow up after various scenarios - how to effectively communicate information - a few points about applicant tracking systems (ATS). Jim and I are asked often about these topics so we thought having a mini-topic episode would be helpful for our listeners. I use ATS systems daily in my recruiting work, so I have included a few thoughts on these to clarify a few frequently asked questions / assumptions. We hope you find this information helpful and enjoy listening!

15

2 Comments

Embarking on a life sciences career? Your CV tells your story - make it count! 🌟 Here are top tips to create a standout CV: 🎯 Tailor to the Role: Adapt your CV to each position, highlighting how your track record aligns with the job details. 📊 Measure Your Impact: Quantify success! Use figures to showcase the tangible results of your work - it's an eye-catcher! 💡 Skills Showcase: Mix technical expertise with soft skills on your CV. Show you're not just skilled, but also a well-rounded asset. 🔍 Clarity Matters: Use plain language that's easy to grasp, even by non-experts. This highlights your communication prowess. 🚀 Continuous Learning: List any additional training or certifications to give you an extra edge. 📝 Be Concise: Keep it sharp and to-the-point, focusing on your latest and most relevant experiences. Update your CV regularly to keep it fresh as your life sciences career flourishes. Use these strategies to not just open doors, but start meaningful discussions. #CareerDevelopment #LifeSciences #CVTips ✨

5

1 Comment